Published in Law and Health Weekly, May 1st, 2010
BioMed also expects to grant the underwriters a 30-day option to purchase an additional 1,350,000 shares to cover over-allotments, if any. Raymond James & Associates, Inc., Morgan...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.